Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NIPPON IYAKUHIN KAIHATSU KENKYUSHO KK
SANKEI YAKUHIN KK
Nippon Pharmaceutical Development Institute Co
Original Assignee
NIPPON IYAKUHIN KAIHATSU KENKYUSHO KK
SANKEI YAKUHIN KK
Nippon Pharmaceutical Development Institute Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NIPPON IYAKUHIN KAIHATSU KENKYUSHO KK, SANKEI YAKUHIN KK, Nippon Pharmaceutical Development Institute CofiledCriticalNIPPON IYAKUHIN KAIHATSU KENKYUSHO KK
Priority to JP12298878ApriorityCriticalpatent/JPS5549381A/en
Publication of JPS5549381ApublicationCriticalpatent/JPS5549381A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
NEW MATERIAL:1-(3-Hydroxypropyl)-3, 7-dimethylxanthine of formula.
USE: Remedy for circulatory disorder, having vascular dilation activity. Since it is easily soluble in lipoid as well as water, it can be easily absorbed through the stomach and the intestines.
PROCESS: The compound of formula is prepared by reacting 3, 7-dimethylxanthine (theobromine) with a 3-halogeno-1-propanol in the presence of an alkali.
COPYRIGHT: (C)1980,JPO&Japio
JP12298878A1978-10-051978-10-051-(3-hydroxypropyl)-3, 7-dimethylxanthine and its preparation
PendingJPS5549381A
(en)